Prot #APL9-COV-201: A Randomized, Double-Blind, Vehicle-Controlled, Multicenter, Parallel-Group Study of APL-9 in Mild to Moderate Acute Respiratory Distress Syndrome Due to COVID-19

Wunderink, Richard G (PD/PI)

Medicine, Pulmonary Division

Project: Research project

Status	Finished
Effective start/end date	6/26/20 → 6/26/23

Funding

Worldwide Clinical Trials, Inc. ((OE) Prot #APL9-COV-201 // (OE) Prot #APL9-COV-201)
Apellis Pharmaceuticals, Inc. ((OE) Prot #APL9-COV-201 // (OE) Prot #APL9-COV-201)